Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years

被引:0
|
作者
Smith, A. [1 ]
Patel, M. [1 ]
Caruso, C. [2 ]
Pilette, C. [3 ]
Welte, T. [4 ]
Alfonso-Cristancho, R. [5 ]
Price, R. G. [6 ]
Howarth, P. [7 ]
机构
[1] Univ Hosp Wishaw, Wishaw, Scotland
[2] Univ Cattolica Sacro Cuore, Rome, Italy
[3] Clin Univ St Luc, Brussels, Belgium
[4] Hannover Med Sch, Hannover, Germany
[5] GSK, Collegeville, PA USA
[6] GSK, Stevenage, Herts, England
[7] GSK, Brentford, Middx, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
000854
引用
收藏
页码:50 / 51
页数:2
相关论文
共 50 条
  • [31] Effect of baseline long- acting muscarinic antagonist use on inhaled corticosteroid/ formoterol dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis
    Korn, S.
    Jandl, M.
    Humbert, M.
    Menzies-Gow, A.
    Shavit, A.
    Olinger, L.
    Jackson, D. J.
    ALLERGOLOGIE, 2024, 47 (09)
  • [32] Inhaled corticosteroid dose reduction with tezepelumab in patients with severe, uncontrolled asthma over 2 years
    Stolz, Daiana
    Lugogo, Njira
    Lawson, Kaitlyn
    Colice, Gene
    Ponnarambil, Sandhia
    Caveney, Scott
    Chandarana, Shradha
    Cook, Bill
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [33] Impact of Atopic Status, Prior Omalizumab Use and Baseline Blood Eosinophil Count Alone and in Combination With Total Serum IgE on Maintenance OCS Reduction Outcomes in Patients With Severe Asthma Treated With Mepolizumab in the REALITI-A Study
    Liu, M. C.
    Chaudhuri, R.
    Chupp, G. L.
    Heaney, L. G.
    Lee, J. K.
    Pilette, C.
    Brusselle, G.
    Cristancho, R. Alfonso
    Zhang, L.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [34] Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysis
    Moore, Wendy C.
    Stach-Klysh, Alexandra
    Corbridge, Thomas
    Packnett, Elizabeth
    Mcmorrow, Donna
    Richards, Megan
    Deb, Arijita
    JOURNAL OF ASTHMA, 2025,
  • [35] Clinical remission in patients with severe eosinophilic asthma treated with benralizumab who were randomised to reduce their inhaled corticosteroid/formoterol dose: SHAMAL post-hoc analysis
    Devouassoux, Gilles
    Jackson, David J.
    Kaessner, Frank F.
    Caruso, Cristiano
    Shavit, Anat
    Olinger, Lynda
    Menzies-Gow, Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [36] Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study
    Papaioannou, Andriana I.
    Kallieri, Maria
    Zervas, Eleftherios
    Fouka, Evangelia
    Porpodis, Konstantinos
    Mitrova, Marija Hadji
    Tzortzaki, Eleni
    Makris, Michael
    Ntakoula, Maria
    Lyberopoulos, Panagiotis
    Dimakou, Katerina
    Koukidou, Sofia
    Ampelioti, Sevasti
    Papaporfyriou, Anastasia
    Katsoulis, Konstantinos
    Kipourou, Maria
    Rovina, Nikoletta
    Antoniou, Katerina
    Vittorakis, Stylianos
    Bakakos, Petros
    Steiropoulos, Paschalis
    Markopoulou, Katerina
    Avarlis, Panteleimon
    Papanikolaou, Ilias C.
    Markatos, Miltiadis
    Gaki, Eleni
    Samitas, Konstantinos
    Glynos, Konstantinos
    Papiris, Spyros A.
    Papakosta, Despoina
    Tzanakis, Nikolaos
    Gaga, Mina
    Kostikas, Konstantinos
    Loukides, Stelios
    ALLERGY AND ASTHMA PROCEEDINGS, 2025, 46 (01) : 45 - 51
  • [37] Real-world outcomes of mepolizumab treatment in severe eosinophilic asthma patients-retrospective cohort study in Slovakia
    Jesenak, Milos
    Vanecek, Vaclav
    Ondrusova, Martina
    Urdova, Veronika
    Dostalova, Katarina
    Hochmuth, Ludek
    BIOMEDICAL PAPERS-OLOMOUC, 2023, 167 (03): : 272 - 280
  • [38] Real-world associations between outcomes and biomarkers in severe asthma patients treated with biologics
    Townend, John
    Tran, Trung N.
    Martin, Neil
    Menzies-Gow, Andrew N.
    Wang, Eileen
    Wechsler, Michael E.
    Canonica, Giorgio Walter
    Heffler, Enrico
    Perez-De-Llano, Luis
    Cosio, Borja G.
    Hew, Mark
    Peters, Matthew
    Gibson, Peter G.
    Bosnic-Anticevich, Sinthia
    Heaney, Liam G.
    Jackson, David J.
    Pfeffer, Paul E.
    Busby, John
    Salvi, Sundeep
    Christoff, George C.
    Popov, Todor A.
    Porsbjerg, Celeste M.
    Torres-Duque, Carlos A.
    Al-Lehebi, Riyad
    Al-Ahmad, Mona
    Perng, Diahn-Warng
    Bergeron, Celine
    Sadatsafavi, Mohsen
    Mahboub, Bassam
    Iwanaga, Takashi
    Maspero, Jorge
    Kuna, Piotr
    Chin, Kook Rhee
    Larenas-Linnemann, Desiree
    Papadopoulos, Nikolaos G.
    Papaioannou, Andriana I.
    Fonseca, Joao A.
    Koh, Mariko Siyue
    Costello, Richard W.
    Price, David
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] REAL-WORLD REDUCTION OF ORAL CORTICOSTEROID USE IN PATIENTS TREATED WITH DUPILUMAB AND WITH MODERATE-TO-SEVERE ASTHMA
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. D. P.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J. A.
    VALUE IN HEALTH, 2023, 26 (06) : S38 - S38
  • [40] Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab:a post-hoc analysis of the 2-year RELIght study
    Papaioannou, Andriana
    Kallieri, Maria
    Zervas, Eleftherios
    Fouka, Evangelia
    Porpodis, Konstaninos
    Hadjimitrova, Marija
    Tzortzaki, Eleni
    Makris, Michael
    Ntakoula, Maria
    Lyberopoulos, Panagiotis
    Dimakou, Katerina
    Koukidou, Sofia
    Ampelioti, Sevasti
    Papaporfyriou, Anastasia
    Katsoulis, Konstantinos
    Kipourou, Maria
    Rovina, Nikoletta
    Antoniou, Katerina
    Vittorakis, Stylianos
    Bakakos, Petros
    Steiropoulos, Paschalis
    Markopoulou, Katerina
    Avarlis, Panteleimon
    Papanikolaou, lias
    Markatos, Miltiadis
    Gaki, Eleni
    Samitas, Konstantinos
    Glynos, Konstantinos
    Papiris, Spyros
    Papakosta, Despoina
    Tzanakis, Nikolaos
    Gaga, Mina
    Kostikas, Konstantinos
    Loukides, Stelios
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64